Therese Maria Liechtenstein
Direktor/Vorstandsmitglied bei 2591046 Ontario Corp.
Ursprung des Netzwerks ersten Grades von Therese Maria Liechtenstein
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands.
47
| Operating Division | Investment Managers | 47 |
FoRx Therapeutics AG
FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology FoRx Therapeutics AG operates as a biotechnology company developing a new generation of cancer drugs focusing on novel deoxyribonucleic acid (DNA) Replication Stress pathways activated in cancer. The firm also provides research and development services. The company was founded by Thanos Halazonetis and Sotirios K. Sotiriou in 2019 and is headquartered in Basel, Switzerland.
8
| Holding Company | Pharmaceuticals: Major | 8 |
2591046 Ontario Corp.
2591046 Ontario Corp. Miscellaneous Commercial ServicesCommercial Services 2591046 Ontario Corp. provides artificial intelligence for reproductive medicine. The company was founded by Rene Bharti, Alex Krivoi, Jim Meriano and Dan Nayot and is headquartered in Toronto, Canada.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Soteria Biotherapeutics, Inc.
Soteria Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Soteria Biotherapeutics, Inc. develops next-generation immunotherapies. Its development allows to control the activity of immunomodulatory therapeutics such as bi-specific T-cell engagers (BiTEs) and CAR T-cells.The company was founded by Zachary Hill and Alexander Martinko and is headquartered in San Francisco, CA.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Therese Maria Liechtenstein
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Rotman School of Management | College/University | Masters Business Admin | |
Amadeus Capital Partners Ltd.
Amadeus Capital Partners Ltd. Investment ManagersFinance Amadeus Capital Partners Ltd is an independent venture capital firm is founded by Anne Glover and Hermann Hauser in 1997. The firm is headquartered in London, UK. | Investment Managers | Private Equity Investor | |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
University of Cambridge | College/University | Undergraduate Degree Graduate Degree | |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Private Equity Analyst | |
The University of Queensland | College/University | Graduate Degree | |
University of St. Andrews | College/University | Undergraduate Degree Undergraduate Degree | |
University of Innsbruck | College/University | Graduate Degree | |
University of Groningen | College/University | Doctorate Degree | |
University of Zurich | College/University | Doctorate Degree | |
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Investment Banks/Brokers | Sales & Marketing | |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
Redalpine Venture Partners AG
Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | Investment Managers | Private Equity Analyst | |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital BV is an Independent Venture Capital firm founded in 2010 by Frank R Landsberger. INKEF Capital BV is headquartered in Amsterdam. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Prexton Therapeutics SA
Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chairman | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
Indi Molecular, Inc.
Indi Molecular, Inc. BiotechnologyHealth Technology Indi Molecular, Inc. is a life sciences company that develops a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. It offers products used by physicians and patients to manage complex and serious diseases like cancer, diabetes, and Alzheimer's. The company was founded by Michael Phelps, Albert A. Luderer, Leroy E. Hood, and Jim Heath in 2013 and is headquartered in Culver City, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Lundbeckfonden Emerge
Lundbeckfonden Emerge Investment ManagersFinance Lundbeckfonden Emerge (Emerge) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2012 and is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor | |
SynAffix BV
SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Calypso Biotech SA
Calypso Biotech SA Pharmaceuticals: MajorHealth Technology Calypso Biotech SA operates as a innovative biopharmaceutical company for gastrointestinal immunological disorders. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Plan-les-Ouates, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Medisafe Project Ltd.
Medisafe Project Ltd. Hospital/Nursing ManagementHealth Services Medisafe Project Ltd. develops a cloud-synced mobile medication management system. Its platform helps the user manage and take medication on time. The company was founded by Omri Shor and Rotem Shor in 2012 and is headquartered in Matam, Israel. | Hospital/Nursing Management | Director/Board Member | |
Inthera Bioscience AG
Inthera Bioscience AG BiotechnologyHealth Technology Inthera Bioscience AG engages in the research in as well as development, production, and distribution of pharmaceutical, biological, and other products used in the fields of human and veterinary medicine. It also provides related consultancy services. The company was founded by Ulrich Kessler and Paramjit Singh Arora on September 20, 2013 and is headquartered in Zurich, Switzerland. | Biotechnology | Chairman Director/Board Member | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Biolinq, Inc.
Biolinq, Inc. Electronic Production EquipmentElectronic Technology Biolinq, Inc. develops skin-applied electronic sensors that analyze body fluids to provide health information. The company was founded by Jared Tangney and Josh Windmiller in 2012 and is headquartered in San Diego, CA. | Electronic Production Equipment | Director/Board Member | |
Sonde Health, Inc.
Sonde Health, Inc. Packaged SoftwareTechnology Services Sonde Health, Inc. develops voice-based technology platform to monitor and diagnose psychological and physical medical conditions. The company was founded by Michael C. Chen and James Harper in 2015 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member | |
iOnctura SA
iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
DNA Script SAS
DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith. | Biotechnology | Director/Board Member | |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Calypso Biotech BV
Calypso Biotech BV BiotechnologyHealth Technology Calypso Biotech BV operates as immunotherapy biotech company. It develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Amsterdam, the Netherlands. | Biotechnology | Director/Board Member | |
Comet Therapeutics, Inc.
Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Genea Biomedx UK Ltd.
Genea Biomedx UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Genea Pty Ltd., Genea Biomedx UK Ltd. is a company that engages in research and development of natural science. Genea Biomedx UK Ltd. is based in Sandwich, UK. Genea Biomedx was founded in 2012. | Miscellaneous Commercial Services | Chief Executive Officer | |
TMRW Life Sciences, Inc.
TMRW Life Sciences, Inc. Information Technology ServicesTechnology Services TMRW Life Sciences, Inc. operates as a platform for in-clinic and remote storage. The company was founded by Joshua Abram, Alan Murray and Jeffrey Port and is headquartered in New York, NY. | Information Technology Services | Chief Executive Officer | |
Pictor Labs, Inc.
Pictor Labs, Inc. Information Technology ServicesTechnology Services Pictor Labs, Inc. engages in technology industry. The company is headquartered in Los Angeles, CA. | Information Technology Services | Director/Board Member | |
PicUP Mobile Ltd.
PicUP Mobile Ltd. Packaged SoftwareTechnology Services PicUP Mobile Ltd. is an Israeli company that specializes in improving the phone call experience for customer service and sales. The company is based in Tel Aviv-Yafo, Israel. The company's patented 'Digital calls' technology adds personalized, interactive digital layers to outbound calls, before, during, and after the call with the agent. Lior Shacham has been the CEO of the company since 2015. | Packaged Software | Director/Board Member | |
ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director/Board Member | |
Myocea | Director/Board Member | ||
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Silver Stone Global Partners | Investment Managers | Private Equity Investor | |
ENGENE HOLDINGS INC. | Biotechnology | Director/Board Member | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Netherlands Vaccine Institute | Corporate Officer/Principal |
Statistik
International
Schweiz | 11 |
Vereinigte Staaten | 11 |
Niederlande | 9 |
Vereinigtes Königreich | 6 |
Israel | 6 |
Sektoral
Health Technology | 21 |
Finance | 12 |
Consumer Services | 8 |
Technology Services | 5 |
Commercial Services | 5 |
Operativ
Director/Board Member | 165 |
Private Equity Analyst | 43 |
Private Equity Investor | 41 |
Corporate Officer/Principal | 33 |
Independent Dir/Board Member | 17 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Joey Mason | 31 |
Roel Bulthuis | 29 |
Colin Goddard | 26 |
Vincent Ossipow | 22 |
Rene Bharti | 19 |
Hakan Goker | 18 |
Dave Rosenberg | 15 |
Jasper Bos | 15 |
Vincent Brichard | 15 |
Louis Villalba | 12 |
Denis Patrick | 12 |
Yoni Blau | 11 |
Andreas Jurgeit | 8 |
Alberto Libanori | 8 |
Arnaud Autret | 7 |
- Börse
- Insiders
- Therese Maria Liechtenstein
- Unternehmensverbindungen